Life Science Success

Send us a textThis week we are taking a brief break from interviewing guests and I am talking about recent changes in the Life Science Success website (www.lifesciencesuccess.com) and an upcoming event with Music Beats Cancer.

Send us a text2022 has turned out to be an extremely pivotal year for computational pathology with major announcements coming out of USCAP and AACR2022. With AI-powered algorithms fueling the excitement in the space across the continuum of clinical trials and diagnostics, there is an increasing interest in unraveling the spatial relationships in the tumor microenvironment. However, the use of 'black-box' algorithms and lack of insights into cell-cell communication, understanding of intermediate cell types, and unambiguous microdomain characterization have hindered the progress in this field. The new SpIntellx platform differentiates itself from other general computational pathology platforms with its focus on spatial intelligence and explainable-AI to reveal insights that help in accelerating discovery, optimizing clinical trials, advancing companion diagnostics, and personalizing therapeutic options. The secret sauce here is the deep understanding of tumor biology from the standpoint of the existence of intermediate cell types and their functional states as well as communication between cells in the tumor environment, thus establishing the new space of Precision Pathology!

Send us a textIn this episode of the Life Science Success Podcast I interviewed Raphael Ognar, CEO and Co-Founder of NKILT Therapeutics.  We discussed his career from product marketing to co-founding a cancer therapy organization.

Send us a textIn this episode of Life Science Success I talked to Dorie Clark for the second time on the show.  Dorie is a marketing strategist and keynote speaker who teaches at Duke University’s Fuqua School of Business and has been named one of the Top 50 business thinkers in the world by Thinkers50. Her latest book is The Long Game: How to Be a Long-Term Thinker in a Short-Term World (HBR Press, 2021) For more information visit: www.lifesciencessuccess.com  

Send us a textThis week on Life Science Success, I interviewed Chris Yeh. Chris is the Co-Author of Blitzscaling. We will be talking about blitzscaling, key factors to blitzscale, and key things Chris looks for when working with companies.

Send us a textThis week on the Life Science Success podcast I interviewed Jason Winder CEO of Sonogen Medical.  Sonogen Medical is a company that has developed a novel technology for ultrasonic bone fracture healing.  

Send us a textIn this episode I interviewed Beth Bauer the Founder and CEO of PosiROI, LLC. Her company focuses on bridging the gaps between business, data, analytics, and technology to maximize shared value creation. https://5280lsc.com/podcast/beth-bauer/      

Send us a textIn this episode of the Life Science Success podcast I interviewed Ross Jackson - Literally, The Man Who Wrote the Book on Patient Recruitment for Clinical Trials using Facebook Ads.     We discuss everything from SEO to current and future challenges in patient recruitment.  

Send us a textDrs. Todd & Kim Saxton are award-winning professors at Indiana University’s Kelley School of Business, as well as co-authors of The Titanic Effect, The book is a practical guide to help startup founders, as well as their investors and supporters, successfully navigate the icebergs that so often sink startups in the ideation and early stages of development. They’ll tap into decades of academic and professional experience in business strategy, entrepreneurship, marketing, market research, and venture-funded startups to help you navigate the “debtbergs” that so often sink early-stage startups.

Send us a textIn this episode of Life Science Success, I interviewed Mark Gordon. Mark is the CEO of Diviner, a company that has developed a novel collective intelligence technique to help investors and biopharma make better drug development decisions. This company is at the intersection of data/analytics and biopharma.